Q32 Bio Inc. (QTTB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 2.66 |
Market Cap | 32.52M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -4.51 |
PE Ratio (ttm) | -0.59 |
Forward PE | n/a |
Analyst | Hold |
Ask | 2.79 |
Volume | 160,392 |
Avg. Volume (20D) | 401,621 |
Open | 2.65 |
Previous Close | 2.68 |
Day's Range | 2.63 - 2.73 |
52-Week Range | 2.58 - 53.79 |
Beta | undefined |
About QTTB
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular ...
Analyst Forecast
According to 7 analyst ratings, the average rating for QTTB stock is "Hold." The 12-month stock price forecast is $12.5, which is an increase of 368.16% from the latest price.